ACHV
ACHV
NASDAQ · Biotechnology

Achieve Life Sciences Inc

$6.32
+0.03 (+0.48%)
Day Range $5.93 — $6.43
52W Range $2.62 — $8.64
Open$6.30
Previous Close$6.29
Day High$6.43
Day Low$5.93
52W High$8.64
52W Low$2.62
Volume—
Avg Volume1.24M
Market Cap697.68M
P/E Ratio—
EPS$-1.55
SectorBiotechnology

Analyst Ratings

Strong Buy
18 analysts
17 Buy 1 Hold 0 Sell
Price Target +404.6% upside
Current
$6.32
Target
$31.89
$22.93 $31.89 avg $41.27

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 55.16B 99.69B 656.40M
Net Income -136,646,939 -222,270,459 10.36M
Profit Margin -397.8% -377.9% 1.6%
EBITDA -137,235,606 -235,629,542 18.53M
Free Cash Flow — — 6.70M
Rev Growth -44.7% -44.7% +1.9%
Debt/Equity 0.69 0.69 0.12

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $294.55 -0.16% 50.3 520.47B
AMGN Amgen Inc $456.60 -1.24% 26.9 252.64B
GILD Gilead Sciences Inc $169.42 +1.10% — 208.95B
VRTX Vertex Pharmaceuticals Inc $531.97 -1.08% 33.9 134.82B
REGN Regeneron Pharmaceuticals $951.08 -0.14% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $159.73 -3.22% 7.7 20.98B